期刊文献+

抗肿瘤靶向脂质体的研究进展 被引量:10

Advances in studies of anti-cancer targeting liposomes
原文传递
导出
摘要 近年来,随着肿瘤靶向治疗在临床的不断推广,抗肿瘤靶向脂质体的研究也备受关注。抗肿瘤靶向脂质体可分为物理靶向脂质体和分子靶向脂质体,前者包括pH敏感脂质体、光敏感脂质体、磁性脂质体和热敏感脂质体;后者包括抗体靶向脂质体、叶酸修饰脂质体、转铁蛋白修饰脂质体、多肽修饰脂质体及糖基修饰脂质体等。现介绍抗肿瘤靶向脂质体的研究进展,为靶向脂质体的研究和应用提供参考。 Anti-cancer targeting liposomes have attracted much attention in recent years with the development of cancer targeting therapy in clinic. Anti-cancer targeting liposomes consist of physical targeting liposomes and molecular targeting liposomes. Physical targeting liposomes include pH sensitive liposomes, photoresponsive liposomes, magnetic liposomes and thermosensitive liposomes, whereas molecular targeting liposomes include antibody conjugated liposomes, folate modified liposomes, transferrin modified liposomes, peptide modified liposomes, glycosyl modified liposomes and so on. An overview of development on anti-cancer targeting liposomes is given here to provide a way for the research and application of targeting liposomes.
出处 《生命科学》 CSCD 2016年第9期1016-1024,共9页 Chinese Bulletin of Life Sciences
基金 国家自然科学基金项目(20876027 211-76046) 国家高新技术研究发展计划("863"计划)(2014AA020707) 中央高校自主科研基金项目(DC120-10104) 辽宁省自然科学基金项目(2013023037)
关键词 抗肿瘤 靶向脂质体 物理靶向 分子靶向 anti-cancer targeting liposomes physical targeting molecular targeting
  • 相关文献

参考文献4

二级参考文献12

  • 1SAPRA P,ALLEN TM. Ligand-targeted liposomal anticancer drugs [ J ]. Prog Lipid Res,2003,42 ( 5 ) :439 - 463.
  • 2HYNES RO. Integrins: a family of cell surface receptors [ J ]. Cell, 1987,48 (4) :549 - 554.
  • 3HYNES RO. Integrins: versatility, modulation, and signaling in cell adhesion [ J ]. Cell, 1992,69 ( 1 ) : 11 - 25.
  • 4ZHANG X,XIE J,LI S,et al. The study on brain targeting of the amphotericin B liposomes [ J ]. J Drug Target, 2003,11 ( 2 ) : 117 - 122.
  • 5KOZIARA JM, LOCKMAN PR, ALLEN DD, et al. Paclitaxel nanoparticles for the potential treatment of brain tumors [ J]. J Control Release .2004.99 ( 2 ):259 - 269.
  • 6ELIAZ RE,SZOKA FC. Liposome-encapsulated doxorubicin targeted to CD44:a strategy to kill CD44-overexpressing tumor cells [ J ]. Cancer Res,2001,61 ( 6 ) :2592 - 2601.
  • 7VERONESE FM,HARRIS JM. Peptide and protein PEGylation III: advances in chemistry and clinical applications [ J ]. Adv Drug Deliv Rev ,2008,60( 1 ) : 1 - 2.
  • 8XIONG XB, MAHMUD A, ULUDA H,et al. Conjugation of Arginine-Glycine-Aspartic acid peptides to poly ( ethylene oxide) -b-poly(-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells [ J ]. Biomacromolecules, 2006,8 (3) :874 -884.
  • 9CANNISTRA SA, OTTENSMEIER C, NILOFF J, et al. Expression and function of beta 1 and alpha v beta 3 integrins in ovarian cancer[ J ]. Gynecol Oncol, 1995,58 (2) :216 - 225.
  • 10CAO Q,CAI W,LI T,et al. Combination of integrin siRNA and irradiation for breast cancer therapy [ J ]. Biochem Biophys Res Commun,2006,351 (3) :726 - 732.

共引文献26

同被引文献128

引证文献10

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部